We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Crystal Analysis Reveals Transcription Factor Binding Structure

By Biotechdaily staff writers
Posted on 13 May 2003
A recent study on the myocyte enhancer factor-2 (MEF2) family of transcription factors describes the crystal structure of the MADS-box/MEF2S domain of human MEF2B bound to a motif of the transcriptional co-repressor Cabin1 and DNA at a resolution of 2.2 angstroms. More...
The structure shows that differences in the protein-binding groove result in different types of MEF2.

The MEF2 family of transcription factors functions in the development and activity of T cells, neuronal cells, and muscle cells. MEF2 is capable of repressing or activating transcription by association with a variety of co-repressors or co-activators in a calcium-dependent manner. MEF2 has been implicated in general inflammation and heart hypertrophy, a condition characterized by enlargement of the heart.

The structure, determined by investigators at the University of Colorado (Boulder, USA) and John Hopkins University (Baltimore, MD, USA), revealed that the required helper proteins are bound in a groove in the top of MEF2. The study was published in the April 17, 2003, issue of Nature.

"Different types of cells have a different subset of four very similar versions of MEF2, each of which binds the same genes but different helper proteins,” explained contributing author Dr. Jun O. Liu, professor of pharmacology and neuroscience at Johns Hopkins. "Now we know that subtle differences in the protein-binding groove give each MEF2 its specificity, preventing a cell from carrying out inappropriate instructions. We do not know what effect blocking MEF2 would have, but we now know it is possible to try.”




Related Links:
University of Colorado
Johns Hopkins University

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
HPV Molecular Test
BD Onclarity HPV Assay
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.